TM6SF2 and metabolic dysfunction-associated steatotic liver disease: Giovanni et al. proved that TM6SF2 rs58542926 could affect nutrient oxidation, glucose homeostasis, and postprandial lipoprotein, adipokine in NAFLD patients [13].